Status:
COMPLETED
Ozoral Pro and Ozoral Gel vs Chlorhexidine Gel 1% for the Management of Peri-implant Mucositis Sites.
Lead Sponsor:
University of Pavia
Conditions:
Peri-implant Mucositis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This is a randomized controlled clinical trial (RCT) with a split-mouth design. After signing the informed consent, patients satisfying the inclusion criteria will undergo supragingival and subgingiva...
Detailed Description
This is a randomized controlled clinical trial (RCT) with a split-mouth design, where a total of 30 patients is expected to be enrolled. After signing the informed consent, patients satisfying the inc...
Eligibility Criteria
Inclusion
- age 18-70 years
- presence of 2 peri-implant mucositis sites per side (left and right) with PD \> 5 mm
- no systemic, metabolic and autoimmune disease
- compliant patients
Exclusion
- neurologic, psychiatric and mental diseases
- patients taking bisphosphonates in the last 12 months
- patients taking antibiotics during the study
- pregnant and breastfeeding women
- patients undergoing anticancer treatment
Key Trial Info
Start Date :
March 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05254275
Start Date
March 22 2022
End Date
June 20 2024
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
Pavia, Lombardy, Italy, 27100